HIGHLIGHTS
- What: The authors compare real-world estimates with pooled, summary-level data available from equivalent RCTs to assess the degree of agreement between the two sources of evidence, and the existence of an efficacy-effectiveness gap in antidepressants. By using the value closest to the specified timepoint, the authors aimed to provide a more accurate representation of the individual`s status at that follow-up period. For this analysis, the authors used only the antidepressants that were studied in both databases, QResearch scientific committee reference 18/EM/0400, 1 July 2019. to 8.51) for mianserin. This . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.